Get the Stockscreener App
7.03
0.57%
+0.04
After Hours:
7.13
0.10
+1.42%
Definitive Healthcare Corp stock is currently priced at $7.03, with a 24-hour trading volume of 285.70K.
It has seen a +0.57% increased in the last 24 hours and a -12.34% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $6.98 pivot point. If it approaches the $7.08 resistance level, significant changes may occur.
Previous Close:
$6.99
Open:
$7.17
24h Volume:
285.70K
Market Cap:
$828.06M
Revenue:
$251.42M
Net Income/Loss:
$-202.39M
P/E Ratio:
-46.87
EPS:
-0.15
Net Cash Flow:
$38.21M
1W Performance:
+0.57%
1M Performance:
-12.34%
6M Performance:
-3.30%
1Y Performance:
-30.53%
1D Range:
$6.97
$7.20
52W Range:
$5.53
$12.46
Definitive Healthcare Corp Stock (DH) Company Profile
Name
Definitive Healthcare Corp
Sector
Industry
Phone
508 720 4224
Address
550 Cochituate Road, Framingham
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-17-24 | Downgrade | Needham | Buy → Hold |
| Jan-05-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-24-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-19-23 | Initiated | William Blair | Outperform |
| Dec-09-22 | Initiated | BofA Securities | Neutral |
| Jul-06-22 | Initiated | Needham | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Feb-24-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Dec-16-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Oct-11-21 | Initiated | Barclays | Equal Weight |
| Oct-11-21 | Initiated | Canaccord Genuity | Hold |
| Oct-11-21 | Initiated | Credit Suisse | Neutral |
| Oct-11-21 | Initiated | Deutsche Bank | Hold |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | JP Morgan | Neutral |
| Oct-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-11-21 | Initiated | Raymond James | Mkt Perform |
| Oct-11-21 | Initiated | Stifel | Buy |
View All
Definitive Healthcare Corp Stock (DH) Latest News
VML and Definitive Healthcare announce partnership to transform key opinion leader management
GlobeNewswire Inc.
Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
GlobeNewswire Inc.
What 4 Analyst Ratings Have To Say About Definitive Healthcare
Benzinga
Challenging Times For Definitive Healthcare: Analysts Highlight Sluggish Growth And Recovery Efforts In Q4 Analysis
Benzinga
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
GlobeNewswire Inc.
Definitive Healthcare Corp. (DH) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Zacks Investment Research
Definitive Healthcare Corp Stock (DH) Financials Data
Definitive Healthcare Corp (DH) Revenue 2024
DH reported a revenue (TTM) of $251.41 million for the quarter ending December 31, 2023, a +12.92% rise year-over-year.
Definitive Healthcare Corp (DH) Net Income 2024
DH net income (TTM) was -$202.39 million for the quarter ending December 31, 2023, a -2,702% decrease year-over-year.
Definitive Healthcare Corp (DH) Cash Flow 2024
DH recorded a free cash flow (TTM) of $38.21 million for the quarter ending December 31, 2023, a +40.22% increase year-over-year.
Definitive Healthcare Corp (DH) Earnings per Share 2024
DH earnings per share (TTM) was -$1.78 for the quarter ending December 31, 2023, a -1,518% decline year-over-year.
About Definitive Healthcare Corp
Definitive Healthcare Corp., through its subsidiaries, provides healthcare commercial intelligence. It offers information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. The company's platform currently offers 13 intelligence modules. It serves life sciences companies, healthcare information technology companies, healthcare providers, and other diversified companies. The company was founded in 2011 and is based in Framingham, Massachusetts.
0.06%
4.53%
Cap:
|
Volume (24h):